Ãâó ½ÃÅ· ¾ËÆÄ
°¡ÀÌ´ø½º Àλó
¹è´ç±Ý Àλó ¹ßÇ¥
¶á±Ý¾øÀÌ ¿Ö ¾Öºêºñ °¡Á®¿Ô³Ä°í ¹°¾îº¸½Å´Ù¸é Á¦°¡ Æò´Ü 111.1 ¿¡ ¹°·ÁÀֱ⠶§¹®ÀÌÁÒ
³î¶ø°Ôµµ »çÀÚ¸¶ÀÚ ........ÇÒ¸»À» ÀÒÀº ..
-
AbbVie (NYSE:ABBV): Q3 Non-GAAP EPS of $3.33 beats by $0.11; GAAP EPS of $1.78 misses by $0.22.
-
Revenue of $14.34B (+11.2% Y/Y) beats by $40M.
-
Raises 2021 GAAP Diluted EPS Guidance Range from $6.04 to $6.14 to $6.29 to $6.33; Raises 2021 Adjusted Diluted EPS Guidance Range from $12.52 to $12.62 to $12.63 to $12.67 vs. $12.57 consensus.
-
Announces 2022 Dividend Increase of 8.5 Percent, Beginning with Dividend Payable in February 2022.